HealthcareServices

Breath Biopsy Testing Sector Forecast Shows Robust Momentum, Climbing to $4.89 Billion With 7.3% CAGR

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the breath biopsy testing market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Breath Biopsy Testing Market?

The breath biopsy testing market has experienced substantial expansion over the past few years. Projections indicate its value will increase from $3.43 billion in 2025 to $3.69 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. This historical growth is primarily driven by factors such as a heightened demand for non-invasive diagnostic methods, increased clinical research focused on breath biomarkers, progress in sensor and spectroscopy technologies, the expansion of diagnostic laboratory services, and a growing patient inclination towards painless testing procedures.

The breath biopsy testing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $4.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing integration of breath-based diagnostics into standard screening procedures, a rise in investments directed towards AI-enabled diagnostic platforms, the broadening scope of personalized medicine applications, the expanding utilization of portable diagnostic tools, and enhanced regulatory backing for non-invasive testing methods. Key trends anticipated within the forecast timeframe encompass the wider acceptance of non-invasive diagnostic approaches, a growing reliance on VOC-based methods for disease identification, the progressive integration of AI-powered breath analysis, the proliferation of portable devices for breath sampling, and a heightened emphasis on early disease screening initiatives.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

What Drivers Are Supporting Technological Adoption In The Breath Biopsy Testing Market?

The growing prevalence of respiratory diseases is projected to drive the expansion of the breath biopsy testing market moving forward. Respiratory diseases are medical conditions that affect the lungs and airways, hindering an individual’s ability to breathe properly. The increased occurrence of these conditions is attributed to factors such as rising environmental pollution, higher rates of smoking, and the increasing incidence of chronic illnesses like asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing becomes essential for respiratory diseases by offering a non-invasive, rapid, and potentially more accurate method for identifying biomarkers associated with these conditions, thus improving early diagnosis and management. For instance, in May 2025, the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, indicated that chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death in the United States in 2023, accounting for 141,733 deaths. During that same year, the age-adjusted prevalence of diagnosed COPD among adults reached 3.8%. Therefore, the increasing prevalence of respiratory diseases will stimulate the growth of the breath biopsy testing market.

Which Segments Are Contributing To The Growth Of The Breath Biopsy Testing Market?

The breath biopsy testing market covered in this report is segmented –

1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

Subsegments:

1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

Which Trends Are Influencing The Performance And Direction Of The Breath Biopsy Testing Market?

Key companies active in the breath biopsy testing market are prioritizing the creation of novel products, such as breath analyzers, aimed at detecting asthma. Breath analyzers serve as diagnostic instruments that identify and quantify specific compounds within an individual’s breath to pinpoint medical conditions or gauge health status. Illustratively, in May 2023, GenWorks, an India-based healthcare solutions provider, unveiled the FenomPro breath analyzer. The FenomPro breath analyzer stands out for its rapid FeNO testing capability, yielding results in just 28 seconds. Engineered for straightforward use in clinical environments, it delivers precise assessments for the diagnosis, screening, and tracking of asthma. This device incorporates a rechargeable battery for ease of transport, features an intuitive user interface, and effectively ascertains whether patients require treatment or inhaler prescriptions.

Who Are The Major Companies Operating In The Breath Biopsy Testing Market?

Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Breath Biopsy Testing Market?

North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Breath Biopsy Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

Smart Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795